Thermostable tetanus and diphtheria vaccine clears trial

SOUTHAMPTON UNIVERSITY

A trehalose-based tetanus and diphtheria vaccine has passed a first human trial in 60 healthy adults, showing a safety profile and immune response comparable to approved vaccines. Larger trials and regulatory review are still needed, but the technology could reduce reliance on refrigeration in remote clinics.